ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AEMD Amundi Luxembourg SA

51.289
0.4334 (0.85%)
23 Dec 2024 - Closed
Realtime Data
Name Symbol Market Type
Amundi Luxembourg SA TG:AEMD Tradegate Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.4334 0.85% 51.289 51.1641 51.4139 51.4382 50.9321 51.4382 2,229 22:50:13

Aethlon Medical to Present at LD MICRO Conference on December 3, 2009

01/12/2009 1:00pm

PR Newswire (US)


Amundi Luxembourg (TG:AEMD)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Amundi Luxembourg Charts.
SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it will present at the LD MICRO Conference on Thursday, December 3, 2009 at 2:00 p.m. (PST) at the Luxe Hotel in Los Angeles. Aethlon Medical's Chairman and CEO, James A. Joyce, will present a corporate overview and will provide an update on the company's clinical progress for its lead product, the Hemopurifier®, a first-in-class artificial adjunct to the immune system proven to capture infectious viruses and immunosuppressive particles from the human circulatory system. (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b) The LD MICRO Conference brings together 75 presenting companies with over 100 institutions focused on investing in small and micro cap companies across a breadth of industries. About Aethlon Medical Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at http://www.aethlonmedical.com/. About LD MICRO LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor. For more information on the list of presenting companies or to register for the event, please visit http://www.ldmicro.com/ or call (408) 457-1042 Contact: At the Company: Jim Frakes Senior VP Finance 858.459.7800 x300 or Jim Joyce Chairman, CEO 858.459.7800 x301 Investor Relations: RedChip Companies, Inc. Jon Cunningham (800) 733-2447, Ext. 107 http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b http://photoarchive.ap.org/ DATASOURCE: Aethlon Medical, Inc. CONTACT: Jim Frakes, Senior VP Finance, +1-858-459-7800, ext. 300, , or Jim Joyce, Chairman, CEO, +1-858-459-7800, ext. 301, , both of Aethlon Medical, Inc.; or Investor Relations, Jon Cunningham of RedChip Companies, Inc., 1-800-733-2447, Ext. 107, , for Aethlon Medical, Inc. Web Site: http://www.aethlonmedical.com/

Copyright

1 Year Amundi Luxembourg Chart

1 Year Amundi Luxembourg Chart

1 Month Amundi Luxembourg Chart

1 Month Amundi Luxembourg Chart

Your Recent History

Delayed Upgrade Clock